The Role of Nutraceuticals in Degenerative Diseases (Part 1)

Nutraceuticals are substances that are not only utilized for nourishment but also as medications. Nutraceuticals are characterized as compounds that offer protection against certain diseases or have physiological benefits. Nutraceuticals are frequently categorized according to their chemical composition, mechanism of action, and food sources, among other factors. Nutraceuticals have been divided into three categories based on their traditional, non-traditional, and commercial uses. These categories have been further subdivided into fortified, recombinant, phytochemical, herbal, and functional foods, as well as dietary supplements, probiotics, and prebiotics. Different kinds of nutraceuticals have a variety of uses depending on their nature. The definitions and categories of nutraceuticals can overlap due to similarities in chemical composition and methods for providing health benefits. Nutraceuticals come in a variety of forms and are currently gaining a lot of interest due to their safe, potential medicinal, and nutritional benefits. Nutraceuticals are effective in treating a wide range of illnesses, including gastrointestinal problems, cancer, diabetes, allergic reactions, arthritis, cardiovascular diseases, and many inflammatory diseases. The main justification for using these nutraceuticals is their wide range of health benefits, which include improving the nutritional value of our diet, possibly extending lifespan by lowering inflammation and oxidative stress, aiding in the prevention and management of certain medical conditions, and meeting the specific dietary requirements of various populations with few adverse effects. Because of this, nutraceuticals are a vital part of a healthy lifestyle. Therefore, in recent years, the nutraceutical sector has grown drastically.

The conventional drug discovery approach is time-consuming, costly, and carries significant risks. Recently, in silico methods have gained considerable attention due to their advantages in cost efficiency, reduced time requirements, and minimized labor. Many new drugs having much higher potential have been developed successfully using a computational approach. In silico approaches have transformed nutraceutical development and optimization, offering expedient and economical methods for identifying bioactive compounds. Derived from natural sources, nutraceuticals show substantial promise in health promotion and disease prevention, particularly for cardiovascular disorders and cancer. This chapter explores the application of in silico methodologies, including molecular docking, Quantitative Structure-Activity Relationship (QSAR) modeling, and molecular dynamics simulations in nutraceutical discovery. It emphasizes the effectiveness of computational methods in predicting bioavailability, therapeutic potential, and safety profiles of nutraceuticals prior to experimental validation. Case studies featuring compounds such as curcumin and resveratrol demonstrate successful implementations of these technologies. This chapter also addresses a list of databases for nutraceutical screening and research. The discussion also addresses inherent limitations and challenges, notably the oversimplification of complex biological systems and computational resource constraints. Looking ahead, the chapter outlines future research trajectories, highlighting the increasing significance of personalized nutraceuticals. These advancements, bolstered by progress in artificial intelligence and quantum computing, carry profound implications for public health strategies and outcomes. Thus, computational tools have become crucial in nutraceutical research for designing and optimizing bioactive compounds with enhanced therapeutic potential.

The progressive and irreversible degradation of cells, tissues, and organs, which aggravate spontaneously over time, is said to be a degenerative disease. Among various cellular and organ systems, degeneration associated with body systems like nervous, cardiovascular, musculoskeletal, ophthalmic, respiratory, hepatocellular, and renal systems is prone to various degenerative disorders. Apart from them, some miscellaneous degenerative diseases like diabetes and arthritis have attracted great concern due to significant health issues globally. Many of these degenerative diseases worsen if genetic and lifestyle management are poorly managed. Excessive alcohol intake, smoking, poor dietary habits, lack of physical activity, and sedentary jobs significantly contributed to most of the deaths related to degenerative conditions. Environmental pollution from industrial waste, chemicals, and solvent exposure, as well as contact with pesticides and heavy metals, may lead to an increased production of reactive oxygen species, causing oxidative stress, DNA damage, and cell death; altogether, they lead to degeneration of cells. Each of the body systems has several degenerative diseases with definite or multiple pathophysiologies. Many of these conditions are incurable and can only be managed to alleviate and improve associated symptoms. Currently, degeneration can be cured, but therapies focus mainly on symptomatic treatment through drugs and herbals, retarding disease progression and improving quality of life. Generally, therapeutic strategies involve regular physical exercise, modification of irregular lifestyle, drug treatment, surgical interventions, biotechnological approaches, and other modern emerging techniques. This chapter summarizes different degenerative diseases, their associated pathophysiological development, and their established as well as proposed therapies.

The class of dietary supplements and natural substances known as “nutraceuticals” presents a potential path for intervention. Degenerative illnesses may become more prevalent in people due to metabolic and systemic disruptions caused by nutritional shortages and imbalances. The primary cause of illness and mortality in both developed and developing countries is degenerative diseases. Degenerative diseases, characterized by a steady decline in organ or tissue function, generate some serious challenges for global healthcare systems. This chapter surveys the current understanding of nutraceuticals concerning degenerative disease, starting with an overview of degenerative diseases and how they affect health, with a special emphasis on how common they are becoming in older populations. Though numerous preclinical and clinical studies have been conducted, these studies are inconclusive due to a lack of toxicological data and small sample sizes. Adequate potential research is required to properly comprehend the underlying mechanisms of action of these nutraceuticals and evaluate their safety, effectiveness, tolerance, dose dependence, and bioavailability in the management of degenerative diseases. Moreover, nutraceuticals are readily accessible, have fewer adverse effects, and offer financial benefits. The high concentration of bioactive substances helps prevent and treat diseases and offers physiological benefits. Herbal nutraceuticals are foods derived from plants, such as their oils, roots, seeds, berries, and flowers. This chapter will aid in understanding the mechanisms by which nutraceuticals function, highlighting their anti-inflammatory and antioxidant properties as well as their capacity to alter cellular pathways implicated in the development of degenerative disease. 

Respiratory diseases encompass a range of conditions affecting the lungs and airways, including acute infections (e.g., bacterial and viral pneumonia) and chronic diseases (e.g., chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, and lung cancer). They also impose significant socio-economic burdens. A number of reasons, including virus outbreaks, the emergence of drug-resistant pathogens, air pollution, smoking, and low immunization rates, have designated respiratory ailments as one of the leading causes of mortality worldwide. Various prevention and control strategies have been adopted to reduce the burden of respiratory illnesses. Among them, nutraceuticals, also known as functional foods, have emerged as one of the most effective choices for supporting respiratory health. Nutraceuticals, including polyunsaturated fatty acids, vitamins, dietary fibers, minerals, and polyphenolic compounds with anti-inflammatory, antioxidant, and immune-modulating properties, have shown promise in managing respiratory diseases by reducing airway inflammation and oxidative stress to improve lung function and disease symptoms. As supplemental therapies, they also maximize the benefits of traditional pharmaceutical treatments while reducing their side effects. Although nutraceuticals appear promising, further studies are needed to determine their optimal formulations and dosing regimens for achieving prolonged benefits. To guarantee the safety and effectiveness of nutraceutical products, standardization and regulatory control are also essential. This chapter first briefly outlines major respiratory illnesses affecting human health. Then, it discusses the functions of promising nutraceuticals in sustaining respiratory health, followed by a highlight of the challenges and considerations associated with their usage.

Primarily characterized by impairment of neurons, neurological disorders stand as one of the most significant challenges to be treated in the global healthcare sector. As the focus shifts towards embracing healthier choices, the demand for nutraceuticals is rapidly rising, particularly for their contribution to neurological disorders, over the past decade, due to their potential to bear lesser or no side effects in contrast to increased therapeutic activity. Neurons, being the functional unit of the brain, are particularly susceptible to any effect on the electrical impulses in the nervous system, which can result in neurological degeneration, whether acquired, congenital, or induced by injury. Neurodegenerative diseases are characterized by neuronal dysfunction or even death of neurons that can affect both the central and peripheral nervous systems. The understanding of the pathophysiology and underlying mechanisms of the main neurodegenerative disorders like Alzheimer’s and Parkinson’s disease is indispensable, while rendering the right treatment is intricate and grim to address. While numerous drugs are currently approved for treating neurodegenerative disorders, the majority of them alleviate associated symptoms rather than addressing the underlying condition. Neuro-nutraceuticals, which are natural plant compounds combining dietary and pharmaceutical properties, play a crucial role. They aim to enhance cerebral blood flow and contribute to illness prevention and management, which can be commonly found in food, herbal remedies, and nutritional supplements. When considering the neuroprotective and neuromodulatory properties of neuronutraceuticals, it is hypothesized that these herbs offer a safer alternative compared to single-target medicines, promoting holistic improvements in brain health with minimal adverse effects. Recently, there has been a significant worldwide increase in the availability and use of nutraceutical products designed to address neurodegenerative diseases. This growth is driven by factors such as relatively lax regulatory oversight and the promotion of these products as safe and effective alternatives to traditional pharmaceuticals. The increasing demand for dietary supplements focused on improving brain health is substantial and poised to create a larger market in the foreseeable future, exerting an influence on both individual well-being and the global economy. 

Degenerative kidney diseases, including chronic kidney disease, diabetic nephropathy, and hypertensive nephropathy, represent significant global health challenges affecting millions worldwide. While conventional treatments remain essential, their limitations and side effects have sparked growing interest in complementary therapeutic approaches. This chapter comprehensively examines the role of nutraceuticals in managing degenerative kidney diseases, synthesizing evidence from both preclinical and clinical studies. Various nutraceuticals, including polyphenols (such as curcumin and resveratrol), omega-3 fatty acids, probiotics, and vitamin D, have demonstrated promising results in modulating key pathological pathways. Preclinical studies have revealed their ability to reduce oxidative stress, inflammation, and metabolic dysregulation, while clinical trials have shown improvements in kidney function markers and associated comorbidities. The chapter examines the mechanisms of action, comparing nutraceutical interventions with conventional treatments and assessing their market value within the expanding global nutraceuticals industry. Despite encouraging results, challenges remain, including standardization issues, limited large-scale clinical evidence, and potential drug interactions. The integration of nutraceuticals into conventional treatment regimens holds promise for improving patient outcomes, particularly in managing inflammation and oxidative stress associated with kidney disease progression. Future research requires larger clinical trials and enhanced quality control measures to establish evidence-based guidelines for the use of nutraceuticals in degenerative kidney diseases. This review offers healthcare professionals and researchers valuable insights into the potential of nutraceuticals as complementary therapeutic options in the management of kidney disease.